Large loss-of-function deletions in RAD52 are very rare according to public databases (gnomAD), and the currently described is the first one reported with nearly 1% carrier frequency in general population in Northern Finland and 2.5% occurrence in cases with an indication of inherited breast cancer predisposition. This evidence concerns the gene RAD52 and breast cancer.